Manic psychosis induced by long term alpha-interferon treatment for hepatitis C

被引:0
|
作者
Howes, OD
McKenzie, KJ
机构
[1] Maudsley Hosp, London SE5 8AF, England
[2] Inst Psychiat, London, England
关键词
mania; psychosis; alpha-interferon; olanzapine; sodium valproate;
D O I
10.3109/13651500009178004
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
There is increasing evidence of psychiatric sine-effects following long-term alpha-interferon treatment, but no previous reports of psychosis as a side-effect. There is little evidence to suggest the best treatment of interferon-related psychiatric illness. A case of manic pyschosis developing after long-term alpha-interferon treatment is reported in a woman with no previous psychiatric history. The patient did not respond to termination of alpha-interferon therapy. She responded partially to olanzapine but completely recovered after sodium valproate was added, with no deleterious effects. Psychiatric sine-effects, including psychosis, are appreciable problems of alpha-interferon. This is the first case report of psychosis developing after long-term treatment. It supports suggestions that the pathological mechanisms of the early and late side-effects are different. Sodium valproate proved to be a safe and effective treatment.
引用
收藏
页码:161 / 162
页数:2
相关论文
共 50 条
  • [31] Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C
    Fujii, H
    Kitada, T
    Yamada, T
    Sakaguchi, H
    Seki, S
    Hino, M
    HEPATO-GASTROENTEROLOGY, 2003, 50 (51) : 841 - 842
  • [32] Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment
    Montalto, G
    Giannitrapani, L
    Soresi, M
    Virruso, L
    di Martino, D
    Gambino, R
    Carroccio, A
    Cervello, M
    INFLAMMATION, 2001, 25 (02) : 101 - 108
  • [33] CONTRIBUTION OF ALPHA-INTERFERON (ALPHA-IFN) TO HIV-INDUCED IMMUNOSUPPRESSION
    LACHGAR, A
    BIZZINI, B
    CELLULAR AND MOLECULAR BIOLOGY, 1995, 41 (03) : 431 - 437
  • [35] Effect of alpha-interferon on natural killer cell activity and lymphocyte subsets in thalassemia patients with chronic hepatitis C
    Malaponte, G
    Passero, E
    Leonardi, S
    Monte, V
    Lauria, C
    Mazzarino, C
    Sciotto, A
    Mancuso, GR
    DiGregorio, F
    Musumeci, S
    ACTA HAEMATOLOGICA, 1997, 98 (02) : 83 - 88
  • [36] Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment
    Montalto, G
    Giannitrapani, L
    Soresi, M
    Florena, A
    Di Martino, D
    Franco, V
    Carroccio, A
    Cervello, M
    INTERVIROLOGY, 2003, 46 (01) : 35 - 42
  • [37] Thrombotic thrombocytopenic purpura in a patient on long-term alpha-interferon therapy for essential thrombocythemia: a case report
    Chunmei Qin
    Dan Yin
    Fang Liu
    Hongyu Qiu
    BMC Nephrology, 24
  • [38] Thrombotic thrombocytopenic purpura in a patient on long-term alpha-interferon therapy for essential thrombocythemia: a case report
    Qin, Chunmei
    Yin, Dan
    Liu, Fang
    Qiu, Hongyu
    BMC NEPHROLOGY, 2023, 24 (01)
  • [39] Combination alpha-interferon and lamivndine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study
    Mutimer, D
    Naoumov, N
    Honkoop, P
    Marinos, G
    Ahmed, M
    de Man, R
    McPhillips, P
    Johnson, M
    Williams, R
    Elias, E
    Schalm, S
    JOURNAL OF HEPATOLOGY, 1998, 28 (06) : 923 - 929
  • [40] Cavernous haemangioma with Kasabach-Merritt syndrome: Treatment with alpha-interferon
    Ettlinger, JJ
    Fleming, PJ
    Joffe, HS
    Kennedy, CTC
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1996, 89 (01) : P55 - P56